1. Cell. 2018 Apr 5;173(2):321-337.e10. doi: 10.1016/j.cell.2018.03.035.

Oncogenic Signaling Pathways in The Cancer Genome Atlas.

Sanchez-Vega F(1), Mina M(2), Armenia J(1), Chatila WK(3), Luna A(4), La KC(3), 
Dimitriadoy S(5), Liu DL(6), Kantheti HS(7), Saghafinia S(2), Chakravarty D(3), 
Daian F(3), Gao Q(8), Bailey MH(8), Liang WW(8), Foltz SM(8), Shmulevich I(9), 
Ding L(10), Heins Z(3), Ochoa A(3), Gross B(3), Gao J(3), Zhang H(3), Kundra 
R(3), Kandoth C(3), Bahceci I(11), Dervishi L(11), Dogrusoz U(11), Zhou W(12), 
Shen H(12), Laird PW(12), Way GP(13), Greene CS(13), Liang H(14), Xiao Y(15), 
Wang C(16), Iavarone A(17), Berger AH(18), Bivona TG(19), Lazar AJ(20), Hammer 
GD(21), Giordano T(22), Kwong LN(23), McArthur G(24), Huang C(25), Tward AD(26), 
Frederick MJ(25), McCormick F(27), Meyerson M(6); Cancer Genome Atlas Research 
Network; Van Allen EM(6), Cherniack AD(6), Ciriello G(28), Sander C(29), Schultz 
N(30).

Collaborators: Caesar-Johnson SJ, Demchok JA, Felau I, Kasapi M, Ferguson ML, 
Hutter CM, Sofia HJ, Tarnuzzer R, Wang Z, Yang L, Zenklusen JC, Zhang JJ, 
Chudamani S, Liu J, Lolla L, Naresh R, Pihl T, Sun Q, Wan Y, Wu Y, Cho J, 
DeFreitas T, Frazer S, Gehlenborg N, Getz G, Heiman DI, Kim J, Lawrence MS, Lin 
P, Meier S, Noble MS, Saksena G, Voet D, Zhang H, Bernard B, Chambwe N, Dhankani 
V, Knijnenburg T, Kramer R, Leinonen K, Liu Y, Miller M, Reynolds S, Shmulevich 
I, Thorsson V, Zhang W, Akbani R, Broom BM, Hegde AM, Ju Z, Kanchi RS, Korkut A, 
Li J, Liang H, Ling S, Liu W, Lu Y, Mills GB, Ng KS, Rao A, Ryan M, Wang J, 
Weinstein JN, Zhang J, Abeshouse A, Armenia J, Chakravarty D, Chatila WK, de 
Bruijn I, Gao J, Gross BE, Heins ZJ, Kundra R, La K, Ladanyi M, Luna A, Nissan 
MG, Ochoa A, Phillips SM, Reznik E, Sanchez-Vega F, Sander C, Schultz N, 
Sheridan R, Sumer SO, Sun Y, Taylor BS, Wang J, Zhang H, Anur P, Peto M, 
Spellman P, Benz C, Stuart JM, Wong CK, Yau C, Hayes DN, Parker JS, Wilkerson 
MD, Ally A, Balasundaram M, Bowlby R, Brooks D, Carlsen R, Chuah E, Dhalla N, 
Holt R, Jones SJM, Kasaian K, Lee D, Ma Y, Marra MA, Mayo M, Moore RA, Mungall 
AJ, Mungall K, Robertson AG, Sadeghi S, Schein JE, Sipahimalani P, Tam A, 
Thiessen N, Tse K, Wong T, Berger AC, Beroukhim R, Cherniack AD, Cibulskis C, 
Gabriel SB, Gao GF, Ha G, Meyerson M, Schumacher SE, Shih J, Kucherlapati MH, 
Kucherlapati RS, Baylin S, Cope L, Danilova L, Bootwalla MS, Lai PH, Maglinte 
DT, Van Den Berg DJ, Weisenberger DJ, Auman JT, Balu S, Bodenheimer T, Fan C, 
Hoadley KA, Hoyle AP, Jefferys SR, Jones CD, Meng S, Mieczkowski PA, Mose LE, 
Perou AH, Perou CM, Roach J, Shi Y, Simons JV, Skelly T, Soloway MG, Tan D, 
Veluvolu U, Fan H, Hinoue T, Laird PW, Shen H, Zhou W, Bellair M, Chang K, 
Covington K, Creighton CJ, Dinh H, Doddapaneni H, Donehower LA, Drummond J, 
Gibbs RA, Glenn R, Hale W, Han Y, Hu J, Korchina V, Lee S, Lewis L, Li W, Liu X, 
Morgan M, Morton D, Muzny D, Santibanez J, Sheth M, Shinbrot E, Wang L, Wang M, 
Wheeler DA, Xi L, Zhao F, Hess J, Appelbaum EL, Bailey M, Cordes MG, Ding L, 
Fronick CC, Fulton LA, Fulton RS, Kandoth C, Mardis ER, McLellan MD, Miller CA, 
Schmidt HK, Wilson RK, Crain D, Curley E, Gardner J, Lau K, Mallery D, Morris S, 
Paulauskis J, Penny R, Shelton C, Shelton T, Sherman M, Thompson E, Yena P, 
Bowen J, Gastier-Foster JM, Gerken M, Leraas KM, Lichtenberg TM, Ramirez NC, 
Wise L, Zmuda E, Corcoran N, Costello T, Hovens C, Carvalho AL, de Carvalho AC, 
Fregnani JH, Longatto-Filho A, Reis RM, Scapulatempo-Neto C, Silveira HCS, Vidal 
DO, Burnette A, Eschbacher J, Hermes B, Noss A, Singh R, Anderson ML, Castro PD, 
Ittmann M, Huntsman D, Kohl B, Le X, Thorp R, Andry C, Duffy ER, Lyadov V, 
Paklina O, Setdikova G, Shabunin A, Tavobilov M, McPherson C, Warnick R, 
Berkowitz R, Cramer D, Feltmate C, Horowitz N, Kibel A, Muto M, Raut CP, Malykh 
A, Barnholtz-Sloan JS, Barrett W, Devine K, Fulop J, Ostrom QT, Shimmel K, 
Wolinsky Y, Sloan AE, De Rose A, Giuliante F, Goodman M, Karlan BY, Hagedorn CH, 
Eckman J, Harr J, Myers J, Tucker K, Zach LA, Deyarmin B, Hu H, Kvecher L, 
Larson C, Mural RJ, Somiari S, Vicha A, Zelinka T, Bennett J, Iacocca M, Rabeno 
B, Swanson P, Latour M, Lacombe L, Têtu B, Bergeron A, McGraw M, Staugaitis SM, 
Chabot J, Hibshoosh H, Sepulveda A, Su T, Wang T, Potapova O, Voronina O, 
Desjardins L, Mariani O, Roman-Roman S, Sastre X, Stern MH, Cheng F, Signoretti 
S, Berchuck A, Bigner D, Lipp E, Marks J, McCall S, McLendon R, Secord A, Sharp 
A, Behera M, Brat DJ, Chen A, Delman K, Force S, Khuri F, Magliocca K, Maithel 
S, Olson JJ, Owonikoko T, Pickens A, Ramalingam S, Shin DM, Sica G, Van Meir EG, 
Zhang H, Eijckenboom W, Gillis A, Korpershoek E, Looijenga L, Oosterhuis W, 
Stoop H, van Kessel KE, Zwarthoff EC, Calatozzolo C, Cuppini L, Cuzzubbo S, 
DiMeco F, Finocchiaro G, Mattei L, Perin A, Pollo B, Chen C, Houck J, 
Lohavanichbutr P, Hartmann A, Stoehr C, Stoehr R, Taubert H, Wach S, Wullich B, 
Kycler W, Murawa D, Wiznerowicz M, Chung K, Edenfield WJ, Martin J, Baudin E, 
Bubley G, Bueno R, De Rienzo A, Richards WG, Kalkanis S, Mikkelsen T, Noushmehr 
H, Scarpace L, Girard N, Aymerich M, Campo E, Giné E, Guillermo AL, Van Bang N, 
Hanh PT, Phu BD, Tang Y, Colman H, Evason K, Dottino PR, Martignetti JA, Gabra 
H, Juhl H, Akeredolu T, Stepa S, Hoon D, Ahn K, Kang KJ, Beuschlein F, Breggia 
A, Birrer M, Bell D, Borad M, Bryce AH, Castle E, Chandan V, Cheville J, Copland 
JA, Farnell M, Flotte T, Giama N, Ho T, Kendrick M, Kocher JP, Kopp K, Moser C, 
Nagorney D, O'Brien D, O'Neill BP, Patel T, Petersen G, Que F, Rivera M, Roberts 
L, Smallridge R, Smyrk T, Stanton M, Thompson RH, Torbenson M, Yang JD, Zhang L, 
Brimo F, Ajani JA, Gonzalez AMA, Behrens C, Bondaruk J, Broaddus R, Czerniak B, 
Esmaeli B, Fujimoto J, Gershenwald J, Guo C, Lazar AJ, Logothetis C, 
Meric-Bernstam F, Moran C, Ramondetta L, Rice D, Sood A, Tamboli P, Thompson T, 
Troncoso P, Tsao A, Wistuba I, Carter C, Haydu L, Hersey P, Jakrot V, Kakavand 
H, Kefford R, Lee K, Long G, Mann G, Quinn M, Saw R, Scolyer R, Shannon K, 
Spillane A, Stretch J, Synott M, Thompson J, Wilmott J, Al-Ahmadie H, Chan TA, 
Ghossein R, Gopalan A, Levine DA, Reuter V, Singer S, Singh B, Tien NV, Broudy 
T, Mirsaidi C, Nair P, Drwiega P, Miller J, Smith J, Zaren H, Park JW, Hung NP, 
Kebebew E, Linehan WM, Metwalli AR, Pacak K, Pinto PA, Schiffman M, Schmidt LS, 
Vocke CD, Wentzensen N, Worrell R, Yang H, Moncrieff M, Goparaju C, Melamed J, 
Pass H, Botnariuc N, Caraman I, Cernat M, Chemencedji I, Clipca A, Doruc S, 
Gorincioi G, Mura S, Pirtac M, Stancul I, Tcaciuc D, Albert M, Alexopoulou I, 
Arnaout A, Bartlett J, Engel J, Gilbert S, Parfitt J, Sekhon H, Thomas G, Rassl 
DM, Rintoul RC, Bifulco C, Tamakawa R, Urba W, Hayward N, Timmers H, Antenucci 
A, Facciolo F, Grazi G, Marino M, Merola R, de Krijger R, Gimenez-Roqueplo AP, 
Piché A, Chevalier S, McKercher G, Birsoy K, Barnett G, Brewer C, Farver C, 
Naska T, Pennell NA, Raymond D, Schilero C, Smolenski K, Williams F, Morrison C, 
Borgia JA, Liptay MJ, Pool M, Seder CW, Junker K, Omberg L, Dinkin M, Manikhas 
G, Alvaro D, Bragazzi MC, Cardinale V, Carpino G, Gaudio E, Chesla D, Cottingham 
S, Dubina M, Moiseenko F, Dhanasekaran R, Becker KF, Janssen KP, 
Slotta-Huspenina J, Abdel-Rahman MH, Aziz D, Bell S, Cebulla CM, Davis A, Duell 
R, Elder JB, Hilty J, Kumar B, Lang J, Lehman NL, Mandt R, Nguyen P, Pilarski R, 
Rai K, Schoenfield L, Senecal K, Wakely P, Hansen P, Lechan R, Powers J, 
Tischler A, Grizzle WE, Sexton KC, Kastl A, Henderson J, Porten S, Waldmann J, 
Fassnacht M, Asa SL, Schadendorf D, Couce M, Graefen M, Huland H, Sauter G, 
Schlomm T, Simon R, Tennstedt P, Olabode O, Nelson M, Bathe O, Carroll PR, Chan 
JM, Disaia P, Glenn P, Kelley RK, Landen CN, Phillips J, Prados M, Simko J, 
Smith-McCune K, VandenBerg S, Roggin K, Fehrenbach A, Kendler A, Sifri S, Steele 
R, Jimeno A, Carey F, Forgie I, Mannelli M, Carney M, Hernandez B, Campos B, 
Herold-Mende C, Jungk C, Unterberg A, von Deimling A, Bossler A, Galbraith J, 
Jacobus L, Knudson M, Knutson T, Ma D, Milhem M, Sigmund R, Godwin AK, Madan R, 
Rosenthal HG, Adebamowo C, Adebamowo SN, Boussioutas A, Beer D, Giordano T, 
Mes-Masson AM, Saad F, Bocklage T, Landrum L, Mannel R, Moore K, Moxley K, 
Postier R, Walker J, Zuna R, Feldman M, Valdivieso F, Dhir R, Luketich J, Pinero 
EMM, Quintero-Aguilo M, Carlotti CG Jr, Dos Santos JS, Kemp R, Sankarankuty A, 
Tirapelli D, Catto J, Agnew K, Swisher E, Creaney J, Robinson B, Shelley CS, 
Godwin EM, Kendall S, Shipman C, Bradford C, Carey T, Haddad A, Moyer J, 
Peterson L, Prince M, Rozek L, Wolf G, Bowman R, Fong KM, Yang I, Korst R, 
Rathmell WK, Fantacone-Campbell JL, Hooke JA, Kovatich AJ, Shriver CD, DiPersio 
J, Drake B, Govindan R, Heath S, Ley T, Van Tine B, Westervelt P, Rubin MA, Lee 
JI, Aredes ND, Mariamidze A.

Author information:
(1)Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan 
Kettering Cancer Center, New York, NY 10065, USA; Human Oncology and 
Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 
10065, USA.
(2)Department of Computational Biology, University of Lausanne (UNIL), 1011 
Lausanne, Vaud, Switzerland and Swiss Institute of Bioinformatics (SIB), 
Lausanne, Switzerland.
(3)Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan 
Kettering Cancer Center, New York, NY 10065, USA.
(4)cBio Center, Dana-Farber Cancer Institute, Boston, MA; Department of Cell 
Biology, Harvard Medical School, Boston, MA.
(5)Princeton University, Princeton, NJ, USA.
(6)Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; 
Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, US.
(7)University of Texas at Dallas, Richardson, TX 75080, USA.
(8)Department of Medicine and McDonnell Genome Institute, Washington University 
in St. Louis, St. Louis, Missouri, 63110, USA.
(9)Institute for Systems Biology, Seattle, WA, USA.
(10)Department of Medicine and McDonnell Genome Institute, Washington University 
in St. Louis, St. Louis, Missouri, 63110, USA; Siteman Cancer Center, Washington 
University School of Medicine, St. Louis, MO 63110, USA.
(11)Computer Engineering Department, Bilkent University, Ankara 06800, Turkey.
(12)Van Andel Research Institute, 333 Bostwick Ave NE, Grand Rapids Michigan, 
49503, USA.
(13)Department of Systems Pharmacology and Translational Therapeutics, 
University of Pennsylvania, Philadelphia, PA, 19104, USA.
(14)Department of Bioinformatics and Computational Biology, The University of 
Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
(15)TESARO Inc., Waltham, MA, 02451, USA.
(16)Department of Health Sciences Research and Department of Obstetrics and 
Gynecology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, 
55905, USA.
(17)Institute for Cancer Genetics, Department of Neurology and Department of 
Pathology and Cell Biology, Columbia University Medical Center, New York, NY, 
10032, USA.
(18)Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA 
98109, USA.
(19)UCSF Helen Diller Family Comprehensive Cancer Center, University of 
California San Francisco, 1450 3rd Street, San Francisco, California 94143, USA.
(20)Departments of Pathology, Genomic Medicine & Translational Molecular 
Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe 
Blvd-Unit 85, Houston, Texas 77030, USA.
(21)Department of Internal Medicine, Division of Metabolism, Endocrinology and 
Diabetes, Endocrine Oncology Program, University of Michigan, Ann Arbor, 
Michigan, MI 48105, USA.
(22)Department of Pathology, University of Michigan Medical School, Ann Arbor, 
MI; Department of Internal Medicine, Division of Metabolism, Endocrinology & 
Diabetes, University of Michigan Medical School, Ann Arbor, MI; Comprehensive 
Cancer Center, Michigan Medicine, Ann Arbor, MI, USA.
(23)Department of Translational Molecular Pathology, The University of Texas MD 
Anderson Cancer Center, Houston, TX, USA.
(24)Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; University of 
Melbourne, Melbourne, VIC, Australia.
(25)Dept. of Otolaryngology, Baylor College of Medicine, USA.
(26)University of California, San Francisco Department of Otolaryngology-Head 
and Neck Surgery. 2233 Post Street, San Francisco, CA, 94143, USA.
(27)UCSF Helen Diller Family Comprehensive Cancer Center, University of 
California San Francisco, 1450 3rd Street, San Francisco, CA 94143, USA.
(28)Department of Computational Biology, University of Lausanne (UNIL), 1011 
Lausanne, Vaud, Switzerland and Swiss Institute of Bioinformatics (SIB), 
Lausanne, Switzerland. Electronic address: Giovanni.Ciriello@unil.ch.
(29)cBio Center, Dana-Farber Cancer Institute, Boston, MA; Department of Cell 
Biology, Harvard Medical School, Boston, MA. Electronic address: 
sander.research@gmail.com.
(30)Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial 
Sloan Kettering Cancer Center, New York, NY 10065, USA; Human Oncology and 
Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 
10065, USA; Departments of Epidemiology and Biostatistics, Memorial Sloan 
Kettering Cancer Center, New York, NY 10065, USA. Electronic address: 
schultz@cbio.mskcc.org.

Comment in
    Pathol Oncol Res. 2020 Jul;26(3):1997-1999. doi: 10.1007/s12253-019-00709-x.

Genetic alterations in signaling pathways that control cell-cycle progression, 
apoptosis, and cell growth are common hallmarks of cancer, but the extent, 
mechanisms, and co-occurrence of alterations in these pathways differ between 
individual tumors and tumor types. Using mutations, copy-number changes, mRNA 
expression, gene fusions and DNA methylation in 9,125 tumors profiled by The 
Cancer Genome Atlas (TCGA), we analyzed the mechanisms and patterns of somatic 
alterations in ten canonical pathways: cell cycle, Hippo, Myc, Notch, Nrf2, 
PI-3-Kinase/Akt, RTK-RAS, TGFβ signaling, p53 and β-catenin/Wnt. We charted the 
detailed landscape of pathway alterations in 33 cancer types, stratified into 64 
subtypes, and identified patterns of co-occurrence and mutual exclusivity. 
Eighty-nine percent of tumors had at least one driver alteration in these 
pathways, and 57% percent of tumors had at least one alteration potentially 
targetable by currently available drugs. Thirty percent of tumors had multiple 
targetable alterations, indicating opportunities for combination therapy.

Copyright © 2018. Published by Elsevier Inc.

DOI: 10.1016/j.cell.2018.03.035
PMCID: PMC6070353
PMID: 29625050 [Indexed for MEDLINE]